全国咨询电话 13068187713

丹参酮IIA磺酸钠CAS: 69659-80-9分析纯 工业级 科研试剂 全国送货 一瓶起售

发布时间: 2025-08-01
中文名丹参酮IIA磺酸钠
英文名sodium 1,6,6-trimethyl-10,11-dioxo-6,7,8,9,10,11-hexahydrophenanthro[1,2-b]furan-2-sulfonate
别名丹参酮IIA磺酸钠
丹参酮IIA磺酸盐
丹参酮IIA-磺酸钠
丹参酮IIA-磺酸钠(标准品)
TANSHINONE IIA-SULFONIC SODIUM 丹参酮IIA-磺酸钠
英文别名DS 201
TanshinoneIIA
Sodium TanshinonⅡA SilateA
Sulfotanshinone sodiuM II-A
Tanshinone ⅡASulfonate SodiuM
SodiuM tanshinone IIA sulfonate
Tanshinone IIA sodium sulfonate
Sulfotanshinone SodiuM Injection
sodium 1,6,6-trimethyl-10,11-dioxo-6,7,8,9,10,11-hexahydrophenanthro[1,2-b]furan-2-sulfonate
SodiuM 1,6,6-triMethyl-10,11-dioxo-6,7,8,9,10,11-hexahydrophenanthro[1,2-b]furan-2-sulfonate
CAS69659-80-9
化学式C19H19NaO6S
分子量398.4
InChIInChI=1/C19H18O6S.Na/c1-9-13-15(20)16(21)14-10-5-4-8-19(2,3)12(10)7-6-11(14)17(13)25-18(9)26(22,23)24;/h6-7H,4-5,8H2,1-3H3,(H,22,23,24);/q;+1/p-1
熔点To dark to Visualize
溶解度DMSO (微溶) 、甲醇 (微溶)
存储条件under inert gas (nitrogen or Argon) at 2-8°C
外观固体
颜色Red
物化性质红色结晶粉末,可溶于甲醇、乙醇、DMSO等有机溶剂,来源于丹参根茎。
MDL号MFCD09028094
体外研究Sodium Tanshinone IIA sulfonate (12.5 μM) inhibits hypoxia-induced PKG and PPAR-γ downregulation in PASMCs and distal pulmonary arteries of rats. The suppressive effects of Sodium Tanshinone IIA sulfonate on TRPC1 and TRPC6 expression in hypoxic PASMCs can be prevented by specific knockdown PKG or PPAR-γ. The suppressive effects of Sodium Tanshinone IIA sulfonate on basal calcium concentration and SOCE in hypoxic PASMCs can be reversed by specific knockdown of PKG or PPAR-γ. PKG-PPAR-γ signaling axis participates in the suppressive effects of Sodium Tanshinone IIA sulfonate on proliferation in hypoxic PASMCs. PPAR-γ agonist promotes the protective role of Sodium Tanshinone IIA sulfonate on basal [Ca 2+ ]i and SOCE in hypoxic PASMCs. Sodium tanshinone IIA sulfonate inhibits the activity of CYP3A4 in a dose-dependent manner by the HLMs and CYP3A4 isoform. The K M and Vmax values of STS are 54.8±14.6 µM and 0.9±0.1 nmol/mg protein/min, respectively, for the HLMs and 7.5±1.4 µM and 6.8±0.3 nmol/nmol P450/min, respectively, for CYP3A4. CYP1A2, CYP2A6, CYP2C9, CYP2D6, CYP2E1, and CYP2C19 show minimal or no effects on the metabolism of STS. Sodium Tanshinone IIA sulfonate inhibits the activity of CYP3A4 in a dose-dependent manner in the HLMs and CYP3A4 isoform. Sodium Tanshinone IIA sulfonate primarily inhibits the activities of CYP3A4 in vitro, and Sodium Tanshinone IIA sulfonate has the potential to perpetrate drug-drug interactions with other CYP3A4 substrates.
体内研究Sodium Tanshinone IIA sulfonate (10 mg/kg, 20 mg/kg) and Donepezil shorten escape latency, increase crossing times of the original position of the platform, and increase the time spent in the target Sodium Tanshinone IIA sulfonate decreases the activity of acetylcholinesterase (AChE) and increases the activity of choline acetyltransferase (ChAT) in the hippocampus and cortex of SCOP-treated mice. Sodium Tanshinone IIA sulfonate increases the activity of superoxide dismutase (SOD) and decreases the levels of malondialdehyde (MDA) and reactive oxygen species (ROS) in hippocampus and cortex. Sodium Tanshinone IIA sulfonate prevention (30 mg/kg/day) alleviates hypoxia-induced characteristic changes in chronic hypoxia PH rat model. Sodium Tanshinone IIA sulfonate (20, 10, and 5 mg/kg, i.p.) effectively prevents peritoneal adhesion without affecting anastomotic healing in the rats. Compared with the adhesion model group, the Sodium Tanshinone IIA sulfonate-treated groups show increased peritoneal lavage fluid tPA activity and tPA/PAI-1 ratio in the ischemic tissues with loared TGF-β1 and collagen I expressions in the ischemic tissues.
参考资料 

查看更多

1. [IF=4.545] Ningning Yang et al."Tanshinone IIA exerts therapeutic effects by acting on endogenous stem cells in rats ...


其他新闻

联系方式

  • 地址:广州 茂名市人民南路198号物业大厦第五层南端505-1号房屋
  • 电话:13068187713
  • 联系人:邓经理
  • 手机:13068187713
  • 微信:13068187713